Reply to: "Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?"

J Hepatol. 2017 Oct;67(4):880-881. doi: 10.1016/j.jhep.2017.05.026. Epub 2017 Jun 8.

Authors

Thomas Reiberger¹, Mattias Mandorfer²

Affiliations

¹ Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria. Electronic address: thomas.reiberger@meduniwien.ac.at.
² Internal Medicine III, Division of Gastroenterology & Hepatology, Medical University of Vienna, Waehringer Guertel 18-20, Austria.

PMID: 28601675
DOI: 10.1016/j.jhep.2017.05.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Acute-On-Chronic Liver Failure*
Adrenergic Agents
Adrenergic beta-Antagonists
Humans
Liver Cirrhosis*

Substances

Adrenergic Agents
Adrenergic beta-Antagonists